What should be done for a 29-year-old woman with a non-tender 1–2 cm palpable mass on the left scalp and a negative ultrasound?

Management of Non-Tender Scalp Mass with Negative Ultrasound

For a 29-year-old woman with a non-tender 1-2 cm palpable scalp mass and negative ultrasound (BI-RADS category 1), you should proceed with either tissue biopsy (core needle or excisional) or close observation at 3-6 month intervals for 1-2 years to assess stability. 1, 2

Clinical Context and Risk Assessment

A non-tender scalp mass in a young woman with negative imaging creates a diagnostic dilemma. While the negative ultrasound is reassuring, the persistence of a palpable finding despite negative imaging warrants further action rather than simple reassurance. In adults over 40, persistent neck/scalp masses carry higher malignancy risk 3, but at age 29, benign etiologies predominate—though malignancy cannot be excluded based on imaging alone.

The non-tender nature is somewhat reassuring (tender masses more often suggest infection), but nontender masses are actually more concerning for malignancy 3. Common benign scalp lesions in this age group include epidermoid cysts, lipomas, pilar cysts, and rarely schwannomas 4. However, malignant entities like leiomyosarcoma 5 and apocrine carcinoma 6 can present similarly.

Recommended Management Algorithm

Option 1: Tissue Diagnosis (Preferred if clinically suspicious)

• Core needle biopsy is preferred over fine-needle aspiration for better histologic characterization 1, 7
• Excisional biopsy is acceptable and may be preferred for scalp lesions given accessibility and definitive diagnosis 1
• Image guidance is not essential for palpable lesions but ensures accurate sampling and allows marker clip placement 7

Option 2: Active Surveillance (If low clinical suspicion)

• Physical examination every 3-6 months for 1-2 years 1, 2
• Consider repeat ultrasound at follow-up visits to document stability
• Proceed to biopsy if the lesion increases in size or changes character 1, 2
• Return to routine screening if stable after surveillance period

Key Decision Points

Choose tissue biopsy immediately if:

• Patient anxiety is significant
• Clinical suspicion remains despite negative imaging
• Patient preference for definitive diagnosis
• Lesion demonstrates any growth or change
• Patient has difficulty with follow-up compliance

Choose surveillance if:

• Clinical examination suggests benign etiology (mobile, soft, well-circumscribed)
• Patient is reliable for follow-up
• Low clinical suspicion overall
• Patient prefers to avoid procedure

Critical Pitfalls to Avoid

1. Do not simply reassure and discharge based on negative ultrasound alone—the discordance between palpable finding and negative imaging requires resolution 1, 2

2. Do not order additional imaging (MRI, CT) as the next step—these are not indicated for initial workup of a palpable scalp mass with negative ultrasound in a young patient without concerning features 8

3. If you choose surveillance, ensure structured follow-up is arranged—approximately one-third of patients with benign ultrasound features can safely avoid immediate biopsy, but documented follow-up is essential 8

4. Document the geographic correlation between the palpable finding and ultrasound examination—ensure the sonographer examined the exact location of the palpable abnormality 2

Practical Implementation

For immediate biopsy approach:

• Excisional biopsy under local anesthesia is straightforward for scalp lesions 4
• Ensure adequate depth to include deep dermis/subcutaneous tissue
• Send entire specimen for histopathology with margins marked

For surveillance approach:

• Document lesion size, consistency, mobility, and exact location at baseline
• Photograph if possible
• Instruct patient on self-monitoring for changes
• Schedule definitive follow-up appointments (not "as needed")
• Lower threshold for biopsy if any interval change occurs

The evidence strongly supports that observation without any intervention is not appropriate 1, 2. The choice between immediate tissue diagnosis versus short-interval surveillance depends on clinical suspicion level, but both require active management rather than dismissal based on negative imaging alone.